These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 2704583)

  • 1. Changes in pulmonary mechanics following caffeine administration in infants with bronchopulmonary dysplasia.
    Davis JM; Bhutani VK; Stefano JL; Fox WW; Spitzer AR
    Pediatr Pulmonol; 1989; 6(1):49-52. PubMed ID: 2704583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Furosemide acutely decreases airways resistance in chronic bronchopulmonary dysplasia.
    Kao LC; Warburton D; Sargent CW; Platzker AC; Keens TG
    J Pediatr; 1983 Oct; 103(4):624-9. PubMed ID: 6620024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dexamethasone therapy for bronchopulmonary dysplasia: improved respiratory mechanics without adrenal suppression.
    Brundage KL; Mohsini KG; Froese AB; Walker CR; Fisher JT
    Pediatr Pulmonol; 1992 Mar; 12(3):162-9. PubMed ID: 1641273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nebulized furosemide in infants with bronchopulmonary dysplasia.
    Rastogi A; Luayon M; Ajayi OA; Pildes RS
    J Pediatr; 1994 Dec; 125(6 Pt 1):976-9. PubMed ID: 7996373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bronchodilators and diuretics in children with bronchopulmonary dysplasia.
    Logvinoff MM; Lemen RJ; Taussig LM; Lamont BA
    Pediatr Pulmonol; 1985; 1(4):198-203. PubMed ID: 3840882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of isoproterenol inhalation on airway resistance in chronic bronchopulmonary dysplasia.
    Kao LC; Warburton D; Platzker AC; Keens TG
    Pediatrics; 1984 Apr; 73(4):509-14. PubMed ID: 6709431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short- and long-term effects of furosemide on lung function in infants with bronchopulmonary dysplasia.
    Engelhardt B; Elliott S; Hazinski TA
    J Pediatr; 1986 Dec; 109(6):1034-9. PubMed ID: 3537245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of oral diuretics on pulmonary mechanics in infants with chronic bronchopulmonary dysplasia: results of a double-blind crossover sequential trial.
    Kao LC; Warburton D; Cheng MH; Cedeño C; Platzker AC; Keens TG
    Pediatrics; 1984 Jul; 74(1):37-44. PubMed ID: 6377221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physiologic effects of terbutaline on pulmonary function of infants with bronchopulmonary dysplasia.
    Sosulski R; Abbasi S; Bhutani VK; Fox WW
    Pediatr Pulmonol; 1986; 2(5):269-73. PubMed ID: 3774383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Respiratory response and pharmacokinetics of intravenous salbutamol in infants with bronchopulmonary dysplasia.
    Kirpalani H; Koren G; Schmidt B; Tan Y; Santos R; Soldin S
    Crit Care Med; 1990 Dec; 18(12):1374-7. PubMed ID: 2173991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What is bronchopulmonary dysplasia and does caffeine prevent it?
    Jensen EA
    Semin Fetal Neonatal Med; 2020 Dec; 25(6):101176. PubMed ID: 33168465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Double-blind, placebo-controlled trial of alternate-day furosemide therapy in infants with chronic bronchopulmonary dysplasia.
    Rush MG; Engelhardt B; Parker RA; Hazinski TA
    J Pediatr; 1990 Jul; 117(1 Pt 1):112-8. PubMed ID: 2196353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased respiratory drive and limited adaptation to loaded breathing in bronchopulmonary dysplasia.
    Greenspan JS; Wolfson MR; Locke RG; Allen JL; Shaffer TH
    Pediatr Res; 1992 Sep; 32(3):356-9. PubMed ID: 1408475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response of pulmonary mechanics to terbutaline in patients with bronchopulmonary dysplasia.
    Brudno DS; Parker DH; Slaton G
    Am J Med Sci; 1989 Mar; 297(3):166-8. PubMed ID: 2923138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequential changes in pulmonary mechanics in the very low birth weight (less than or equal to 1000 grams) infant.
    Greenspan JS; Abbasi S; Bhutani VK
    J Pediatr; 1988 Oct; 113(4):732-7. PubMed ID: 3171798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early changes in respiratory compliance and resistance during the development of bronchopulmonary dysplasia in the era of surfactant therapy.
    Lui K; Lloyd J; Ang E; Rynn M; Gupta JM
    Pediatr Pulmonol; 2000 Oct; 30(4):282-90. PubMed ID: 11015127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction between chest wall motion and lung mechanics in normal infants and infants with bronchopulmonary dysplasia.
    Allen JL; Greenspan JS; Deoras KS; Keklikian E; Wolfson MR; Shaffer TH
    Pediatr Pulmonol; 1991; 11(1):37-43. PubMed ID: 1833720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized placebo-controlled study to evaluate the effects of oral albuterol on pulmonary mechanics in ventilator-dependent infants at risk of developing BPD.
    Stefano JL; Bhutani VK; Fox WW
    Pediatr Pulmonol; 1991; 10(3):183-90. PubMed ID: 1852516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of early caffeine therapy in preterm newborns on infant lung function.
    Sanchez-Solis M; Garcia-Marcos PW; Agüera-Arenas J; Mondejar-Lopez P; Garcia-Marcos L
    Pediatr Pulmonol; 2020 Jan; 55(1):102-107. PubMed ID: 31587528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary effect of inhaled furosemide in ventilated infants with severe bronchopulmonary dysplasia.
    Kugelman A; Durand M; Garg M
    Pediatrics; 1997 Jan; 99(1):71-5. PubMed ID: 8989341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.